TNONNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TNONW

Tenon Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$2.45−0.25 (-9.26%)

Close on Oct 19, 2026

Market cap: $804
P/E (TTM): –
Dividend yield: –

Tenon Medical, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation & Amortization	0.26	0.41	0.20	0.08	–
Stock-Based Compensation	1.69	3.85	4.15	2.90	0.38
Change in Accounts Receivable	-0.85	-0.39	-0.29	-0.15	-0.06
Change in Inventory	-0.39	-0.05	-0.14	-0.23	-0.15
Change in Accounts Payable	0.49	-0.06	-0.12	0.07	0.44
Operating Cash Flow	-11	-9.88	-12	-12	-4.29
Capital Expenditures	-0.27	-0.19	-0.36	-0.85	-0.10
Purchase of Investments	–	–	-0.49	-10	-4.40
Sale & Maturity of Investments	–	–	7.00	8.08	0
Investing Cash Flow	-1.02	-0.19	6.14	-2.88	-4.50
Stock Issued	–	2.11	0.50	14	0
Debt Issued	–	–	0.50	–	–
Financing Cash Flow	8.99	14	6.30	14	11
Foreign Exchange Rate Adjustments	–	0.05	0.04	0.01	0.00
Net Change in Cash	-2.78	4.11	0.30	-0.79	2.67
Free Cash Flow	-11	-10	-13	-13	-4.39
Income Taxes Paid	–	–	–	0	0.00
Interest Paid	–	–	–	0	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 66.8%
Operating margin: -242.7%
Net margin: -257.9%
Return on equity, FY2025: -228.1%

Financial strength

Current ratio: 0.58
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 20.2%

Valuation

P/E ratio: –
Price to sales: 0.00
Price to book: –
Dividend yield: –